Chronic spontaneous urticaria: delays in access to specialist review are prolonged and highlight clinical and psychosocial burden
Skin Health and Disease · 06.11.2026
DOI: 10.1093/skinhd/vzag173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Skin Health and Disease, online erschienen am 06.11.2026. Verfasst von Karishma Mahtani und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients with chronic spontaneous urticaria (CSU) experience substantial delays before specialist assessment, with a mean time from symptom onset to review of 46 months – far exceeding the 6-week National Institute for Health and Care Excellence (NICE) referral benchmark. In this tertiary care cohort, over one-third of patients had severe clinical disease and more than a quarter were experiencing a severe psychosocial impact at presentation, with clinical and psychosocial severity strongly correlated. Patients with milder cases of CSU appeared to remain in primary care for prolonged periods without escalation, and psychosocial assessment was inconsistent across the referral pathway. These findings highlight the need for earlier primary care optimization, stronger adherence to NICE guidance and integrated psychosocial assessment to reduce disease burden and improve outcomes.
Zitieren
APA
Mahtani, K., Gkini, M., & Bewley, A. P. (2026). Chronic spontaneous urticaria: delays in access to specialist review are prolonged and highlight clinical and psychosocial burden. Skin Health and Disease. https://doi.org/10.1093/skinhd/vzag173
Vancouver
Mahtani K, Gkini M, Bewley AP. Chronic spontaneous urticaria: delays in access to specialist review are prolonged and highlight clinical and psychosocial burden. Skin Health and Disease. 2026. doi:10.1093/skinhd/vzag173
BibTeX
@article{Mahtani2026,
author = {Mahtani, Karishma and Gkini, Maria-Angeliki and Bewley, Anthony P},
title = {Chronic spontaneous urticaria: delays in access to specialist review are prolonged and highlight clinical and psychosocial burden},
journal = {Skin Health and Disease},
year = {2026},
doi = {10.1093/skinhd/vzag173}
}
EUVIMED